Concepedia

Charles E. Chandler

CE

Statistics

Publications

13

Citations

967

H-Index

12

Active since

1980

Affiliations

Pfizer (United States)(Current)

University of California, Los Angeles

Jet Propulsion Laboratory

California Institute of Technology

The Aerospace Corporation

Charles E. Chandler is an author at Pfizer (United States) specializing in medicine, pharmacology, and physiology.

Top concepts

Publications per year

1980–1999

13

Publications

13

A monoclonal antibody modulates the interaction of nerve growth factor with PC12 cells.

Charles E. Chandler, Linda M. Parsons, Markus Hosang et al. · Journal of Biological Chemistry · 1984 · 502 citations · Full text

<title>New advancements in charge-coupled device technology: subelectron noise and 4096 x 4096 pixel CCDs</title>

James R. Janesick, Tom Elliott, Arsham Dingiziam et al. · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · 1990 · 81 citations

, , +16

Comparison of synthetic saponin cholesterol absorption inhibitors in rabbits: evidence for a non-stoichiometric, intestinal mechanism of action

Lee A. Morehouse, F.W. Bangerter, Michael P. DeNinno et al. · Journal of Lipid Research · 1999 · 71 citations · Full text

Tumor promoter modulation of epidermal growth factor‐ and nerve growth factor‐induced adhesion and growth factor binding of PC‐12 pheochromocytoma cells

Charles E. Chandler, Harvey R. Herschman · Journal of Cellular Physiology · 1980 · 58 citations

A monoclonal antibody which inhibits epidermal growth factor binding has opposite effects on the biological action of epidermal growth factor in different cells.

L P Chandler, Charles E. Chandler, Markus Hosang et al. · Journal of Biological Chemistry · 1985 · 51 citations · Full text

1–5 of 13